Correlation Between Akari Therapeutics and Icosavax
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Icosavax, you can compare the effects of market volatilities on Akari Therapeutics and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Icosavax.
Diversification Opportunities for Akari Therapeutics and Icosavax
-0.89 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akari and Icosavax is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Icosavax go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Icosavax
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Icosavax. In addition to that, Akari Therapeutics is 1.02 times more volatile than Icosavax. It trades about -0.03 of its total potential returns per unit of risk. Icosavax is currently generating about 0.0 per unit of volatility. If you would invest 1,072 in Icosavax on November 2, 2024 and sell it today you would lose (170.00) from holding Icosavax or give up 15.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 22.72% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Icosavax
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Akari Therapeutics and Icosavax Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Icosavax
The main advantage of trading using opposite Akari Therapeutics and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |